{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:39:48Z","timestamp":1793410788734,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572174"],"award-info":[{"award-number":["81572174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Tranexamic acid (TXA) is widely used to reduce blood loss and transfusion rates in total hip arthroplasty(THA). Thromboelastography, which can monitor coagulation changes from clotting to fibrinolysis dynamically. In this study, thromboelastography was used to assess the dynamic changes in the coagulation of patients who underwent THA with the administration of TXA.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This randomized controlled trial consisted of 207 consecutive patients who underwent primary total hip arthroplasty. Patients were randomized into three groups: topical-TXA group received a topical application of TXA, IV-TXA group received an intravenous injection of TXA, and control group. Thromboelastography was performed 1 day before surgery and first, fourth, seventh days after surgery. The primary outcomes were thromboelastography parameters, the rates of deep vein thrombosis(DVT), and pulmonary embolism(PE). Secondary outcomes included perioperative blood loss, transfusion rates, and other perioperative complications.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The mean calculated total blood loss in the Topical-TXA group were 832.7 \u00b1 279.84 ml and 834.8 \u00b1 322.94 ml in the IV-TXA group, which were significantly reduced (<jats:italic>p<\/jats:italic> &lt; 0.05) compared with control groups at 1093.3 \u00b1 379.7 ml. There were no significant differences between topical-TXA and IV-TXA groups in total blood loss or transfusion rates. <jats:italic>K<\/jats:italic> and <jats:italic>R<\/jats:italic> have reached a nadir from preoperative levels to 4th day postoperatively and then began to increase.\u03b1 angle and CI peaked from preoperative levels to the fourth day postoperatively and then began to decline.IV-TXA significantly (<jats:italic>p<\/jats:italic> &lt; 0.05) promoted coagulation levels compared with topical-TXA and control groups in the early postoperative period. Almost no significant differences were observed between topical-TXA and control groups in thromboelastography parameters.No significant differences were observed in the incidence of thromboembolic complications and other perioperative complications.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The topical administration of TXA had the same hemostatic effect as intravenous injection tranexamic acid. Coagulation function peaked on 4th day postoperatively and then began to decline. IV-TXA was more enhanced coagulation functions compared with topical-TXA.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13018-019-1497-y","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T15:04:53Z","timestamp":1576076693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Application of thromboelastography to evaluate the effect of different routes administration of tranexamic acid on coagulation function in total hip arthroplasty"],"prefix":"10.1186","volume":"14","author":[{"given":"Xingming","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huading","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"1497_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1302\/0301-620X.72B3.2341445","volume":"72","author":"GC Bannister","year":"1990","unstructured":"Bannister GC, Young SK, Baker AS, Mackinnon JG, Magnusson PA. Control of bleeding in cemented arthroplasty. J Bone Joint Surg Br. 1990;72:444\u20136.","journal-title":"J Bone Joint Surg Br"},{"key":"1497_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2165\/00003495-198529030-00003","volume":"29","author":"M Verstraete","year":"1985","unstructured":"Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985;29:236\u201361.","journal-title":"Drugs."},{"key":"1497_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13018-018-1028-2","volume":"14","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Ma J, Ma X. Comparative efficacy and safety of different hemostatic methods in total hip arthroplasty: a network meta-analysis.Journal of Orthopaedic Surgery and. Research. 2019;14:4. https:\/\/doi.org\/10.1186\/s13018-018-1028-2.","journal-title":"Research."},{"issue":"6","key":"1497_CR4","first-page":"1306","volume":"31","author":"X Xu","year":"2015","unstructured":"Xu X, Li X, Liu W, Wang Z. Longtime soaking of high concentration tranexamic acid in total hip arthroplasty: A prospective randomized controlled trial in 224 patients. Pak J Med Sci. 2015;31(6):1306\u201311.","journal-title":"Pak J Med Sci"},{"key":"1497_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.thromres.2019.02.006","volume":"176","author":"S Xu","year":"2019","unstructured":"Xu S, Chen JY, Zheng Q, Lo NN, Chia SL, Tay KJD, Pang HN, Shi L, Chan ESY, Yeo SJ. The safest and most efficacious route of tranexamic acid administration in total joint arthroplasty: A systematic review and network meta-analysis. Thromb Res. 2019;176:61\u20136.","journal-title":"Thromb Res"},{"issue":"10","key":"1497_CR6","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1016\/j.arth.2018.06.023","volume":"33","author":"YA Fillingham","year":"2018","unstructured":"Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Shores P, Mullen K, Bini SA, Clarke HD, Schemitsch E, Johnson RL, Memtsoudis SG, Sayeed SA, Sah AP, Della Valle CJ. The efficacy of tranexamic acid in total hip arthroplasty: a network Meta-analysis. J Arthroplasty. 2018;33(10):3083\u20139.","journal-title":"J Arthroplasty"},{"issue":"10","key":"1497_CR7","doi-asserted-by":"publisher","first-page":"e0206480","DOI":"10.1371\/journal.pone.0206480","volume":"13","author":"BH Yoon","year":"2018","unstructured":"Yoon BH, Kim TY, Ko YS, Lee YK, Ha YC, Koo KH. Optimal use of tranexamic acid for total hip arthroplasty:A network meta-analysis. PloS One. 2018;13(10):e0206480. https:\/\/doi.org\/10.1371\/journal.pone.0206480.","journal-title":"PloS One"},{"issue":"2","key":"1497_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1302\/0301-620X.101B2.BJJ-2018-0898.R1","volume":"101-B","author":"A Clav\u00e9","year":"2019","unstructured":"Clav\u00e9 A, G\u00e9rard R, Lacroix J, Baynat C, Danguy des D\u00e9serts M, Gatineau F, Mottier D. A randomized,double-blind,placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty. Bone Joint J. 2019;101-B(2):207\u201312.","journal-title":"Bone Joint J"},{"issue":"1","key":"1497_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12891-018-2358-2","volume":"19","author":"X Han","year":"2018","unstructured":"Han X, Gong G, Han N, Liu M. Efficacy and safety of oral compared with intravenous tranexamic acid in reducing blood loss after primary total knee and hip arthroplasty: a meta-analysis. BMC Musculoskelet Disord. 2018;19(1):430.","journal-title":"BMC Musculoskelet Disord"},{"issue":"13","key":"1497_CR10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2106\/JBJS.17.00641","volume":"100","author":"JM Wilde","year":"2018","unstructured":"Wilde JM, Copp SN, McCauley JC, Bugbee WD. One dose of intravenous tranexamic acid is equivalent to two doses in total hip and knee arthroplasty. J Bone Joint Surg Am. 2018;100(13):1104\u20139.","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"1497_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13478","volume":"33","author":"JU Yoon","year":"2019","unstructured":"Yoon JU, Cheon JH, Choi YJ, Byeon GJ, Ahn JH, Choi EJ, Park JY. The correlation between conventional coagulation tests and thromboelastography in each phase of liver transplantation. Clin Transplant. 2019;33(3):e13478.","journal-title":"Clin Transplant."},{"issue":"3","key":"1497_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.transproceed.2018.12.030","volume":"51","author":"RAS Campbell","year":"2019","unstructured":"Campbell RAS, Thomson EM, Beattie C. Effect of liver disease etiology on ROTEM profiles in patients undergoing liver transplantation. Transplant Proc. 2019;51(3):783\u20139.","journal-title":"Transplant Proc."},{"issue":"02","key":"1497_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4103\/aca.ACA_4_17","volume":"20","author":"V Bhardwaj","year":"2017","unstructured":"Bhardwaj V, Malhotra P, Hasija S, Chowdury UK, Pangasa N. Coagulopathies in cyanotic cardiac patients: an analysis with three point-of-care testing devices (Thromboelastography, rotational thromboelastometry,and sonoclot analyzer). Ann Card Anaesth. 2017;20(02):212\u20138.","journal-title":"Ann Card Anaesth"},{"issue":"3","key":"1497_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1055\/s-0038-1670683","volume":"35","author":"D Zavlin","year":"2019","unstructured":"Zavlin D, Chegireddy V, Jubbal KT, Agrawal NA, Spiegel AJ. Management of microsurgical patients using intraoperative unfractionated heparin and thromboelastography. J Reconstr Microsurg. 2019;35(3):198\u2013208.","journal-title":"J Reconstr Microsurg"},{"key":"1497_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11239-014-1130-1","volume":"40","author":"F Franchi","year":"2015","unstructured":"Franchi F, Hammad JS, Rollini F, et al. Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists. J Thromb Thrombolysis. 2015;40:118\u201325.","journal-title":"J Thromb Thrombolysis"},{"key":"1497_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/313854","volume":"2011","author":"EB Bachli","year":"2011","unstructured":"Bachli EB, B\u00f6siger J, B\u00e9chir M, Stover JF, Stocker R, Maggiorini M, Renner EL, M\u00fcllhaupt B, Schuepbach RA. Thromboelastography to monitor clotting\/bleeding complications in patients treated with the molecular adsorbent recirculating system. Crit Care Res Pract. 2011;2011:1.","journal-title":"Crit Care Res Pract"},{"key":"1497_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1476-4431.2005.04025.x","volume":"15","author":"SM Donahue","year":"2005","unstructured":"Donahue SM, Otto CM. Thromboelastography:A tool for measuring hypercoagulability,hypocoagulability,and fibrinolysis. J Vet Emerg Crit Care. 2005;15:9\u201316.","journal-title":"J Vet Emerg Crit Care"},{"key":"1497_CR18","first-page":"224","volume":"51","author":"SB Nadler","year":"1962","unstructured":"Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51:224\u201332.","journal-title":"Surgery."},{"key":"1497_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00000542-198303000-00016","volume":"58","author":"JB Gross","year":"1983","unstructured":"Gross JB. Estimating allowable blood loss:corrected for dilution. Anesthesiology. 1983;58:277\u201380.","journal-title":"Anesthesiology"},{"issue":"6","key":"1497_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2217\/cer-2018-0120","volume":"8","author":"L Wang","year":"2019","unstructured":"Wang L, Cao JG, Liu J. Comparison between oral and intravenous application of tranexamic acid for total hip arthroplasty: a meta-analysis. J Comp Eff Res. 2019;8(6):423\u201330.","journal-title":"J Comp Eff Res"},{"issue":"21","key":"1497_CR21","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2106\/JBJS.L.00908","volume":"95","author":"S Alshryda","year":"2013","unstructured":"Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin AP. Topical(intra-articular)tranexamic acid reduces blood loss and transfusion rates following total hip replacement:a randomized controlled trial(TRANX-H). J Bone Joint Surg Am. 2013;95(21):1969\u201374.","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"1497_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.arth.2013.05.026","volume":"29","author":"TC Wind","year":"2014","unstructured":"Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty. 2014;29(2):387\u20139.","journal-title":"J Arthroplasty"},{"issue":"5","key":"1497_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.arth.2013.10.005","volume":"29","author":"JG Martin","year":"2014","unstructured":"Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH. Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplasty. 2014;29(5):889\u201394.","journal-title":"J Arthroplasty."},{"issue":"21","key":"1497_CR24","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2106\/JBJS.L.00907","volume":"95","author":"S Alshryda","year":"2013","unstructured":"Alshryda S, Mason J, Vaghela M, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am. 2013;95(21):1961\u20138.","journal-title":"J Bone Joint Surg Am"},{"issue":"36","key":"1497_CR25","first-page":"e4689","volume":"95","author":"J Li","year":"2016","unstructured":"Li J, Zhang Z, Chen J. Comparison of efficacy and safety of topical versus intravenoustranexamic acid in total hip arthroplasty: A meta-analysis. Medicine(Baltimore). 2016;95(36):e4689.","journal-title":"Medicine(Baltimore)"},{"issue":"50","key":"1497_CR26","doi-asserted-by":"publisher","first-page":"e5573","DOI":"10.1097\/MD.0000000000005573","volume":"95","author":"P Zhang","year":"2016","unstructured":"Zhang P, Liang Y, Chen P, Fang Y, He J, Wang J. Intravenous versus topical tranexamic acid in primary total hip replacement: A meta-analysis. Medicine (Baltimore). 2016;95(50):e5573.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1497_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/anae.13765","volume":"72","author":"A Wikkels\u00f8","year":"2017","unstructured":"Wikkels\u00f8 A, Wetterslev J, M\u00f8ller AM, Afshari A. Thromboelastography (TEG) or rotational thromboelastometry (ROTEM) to monitor haemostatic treatment in bleeding patients: a systematic review with meta-analysis and trial sequential analysis. Anaesthesia. 2017;72(4):519\u201331.","journal-title":"Anaesthesia."},{"issue":"10","key":"1497_CR28","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1016\/j.transproceed.2018.07.032","volume":"50","author":"RB Hawkins","year":"2018","unstructured":"Hawkins RB, Raymond SL, Hartjes T, Efron PA, Larson SD, Andreoni KA, Thomas EM. Review: The perioperative use of thromboelastography for liver transplant patients. Transplant Proc. 2018;50(10):3552\u20138.","journal-title":"Transplant Proc."},{"key":"1497_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bjh.13930","volume":"173","author":"GA Hans","year":"2016","unstructured":"Hans GA, Besser MW. The place of viscoelastic testing in clinical practice. Br J Haematol. 2016;173:37\u201348.","journal-title":"Br J Haematol."},{"issue":"1","key":"1497_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/0259-1162.128908","volume":"8","author":"WM Emara","year":"2014","unstructured":"Emara WM, Moez KK, Elkhouly AH. Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesth Essays Res. 2014;8(1):48\u201353.","journal-title":"Anesth Essays Res"},{"issue":"15","key":"1497_CR31","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2106\/JBJS.I.01518","volume":"92","author":"J Wong","year":"2010","unstructured":"Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, Syed KA, Muhammad Ovais Hasan S, De Silva Y, Chung F. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized,controlled trial. J Bone Joint Surg Am. 2010;92(15):2503\u201313.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"1497_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13018-019-1250-6","volume":"14","author":"XD Wu","year":"2019","unstructured":"Wu XD, Chen Y, Tian M, He Y, Tao YZ, Xu W, Cheng Q, Chen C, Liu W, Huang W. Application of thrombelastography (TEG) for safety evaluation of tranexamic acid in primary total joint arthroplasty. J Orthop Surg Res. 2019;14(1):214.","journal-title":"J Orthop Surg Res"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-019-1497-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13018-019-1497-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-019-1497-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T01:03:00Z","timestamp":1607562180000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-019-1497-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1497"],"URL":"https:\/\/doi.org\/10.1186\/s13018-019-1497-y","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"7 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethic approval of this study was obtained from the Institutional Ethics Committee of The First Affiliated Hospital of Nanchang University. Informed and written consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"430"}}